EUAA

Guardant360 CDx is the fastest CGP panel
with guideline-recommended biomarkers.^1-4*

The market leader in liquid biopsy,
backed by the strongest legacy in blood-based NGS.

IVDR-certified comprehensive liquid biopsy with results in 7 days^2†

For the complete intended use statement including companion diagnostic indications,
please see the Guardant360 CDx Technical Information: Guardant360CDx.com/technicalinfo.

Product availability may vary depending on region.

Certified and compliant

Trusted by more than
15,000 oncologists

CGP, comprehensive genomic profiling; IVDR, In Vitro Diagnostic Regulation;
NGS, next-generation sequencing.
*Fastest refers to turnaround time based on Guardant Health data on file.
†7-day turnaround time from sample receipt to results.

Next >

Home Oncology Portfolio Partnerships European Policy